Verona Pharma

VRNA

David Ebsworth is Non-Executive Chairman at Verona Pharma Plc. His career spans over 35 years in the global pharmaceutical industry, during which he was Global Head of Pharmaceuticals at Bayer AG and CEO of a number of companies, including ViforPharma and Galenica. He is also an advisor to a variety …

Insider trades and stock quote 2023-2025

70.070.060.060.050.050.040.040.030.030.020.020.010.010.0Apr '23Apr '23Jun '23Jun '23Aug '23Aug '23Oct '23Oct '23Dec '23Dec '23Feb '24Feb '24Apr '24Apr '24Jun '24Jun '24Aug '24Aug '24Oct '24Oct '24Dec '24Dec '24Feb '25Feb '25Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (4)Sell (3)Sell (3)Sell (3)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)Sell (2)SellSellSellSellSellSellSellBuy (2)Buy (2)BuyBuyBuyBuy

All insider trades at Verona Pharma

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
3/12/2025 SellRickard, Kathleen A. Chief Medical Officer $8.4 $661,942
12/6/2024 SellHahn, Mark W. Chief Financial Officer $5.0 $920,312
12/6/2024 SellZaccardelli, David President and CEO $5.0 $815,400
12/5/2024 SellHahn, Mark W. Chief Financial Officer $5.0 $3,204,144
12/5/2024 SellZaccardelli, David President and CEO $5.0 $3,205,226
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)

Free Updates via Email

Get a summary with the most interesting insider trades of the last weeks.
See data protection agreement.